Medical Care of Patient with HIV-Associated Kaposi’s Sarcoma: Case Report

被引:0
|
作者
Zeliha Genç
Dilek Yildirim
Ferda Akyüz Özdemir
Süda Tekin
机构
[1] Koç University Hospital,Department of Infection Control Nursing
[2] İstanbul Aydın University,Faculty of Health Sciences, Department of Nursing
[3] Mugla Sitki Kocman University,Fethiye Faculty of Health Sciences, Department of Nursing
[4] Koç University School of Medicine,Department of Infectious Diseases and Clinical Microbiology
关键词
HIV; Kaposi’s sarcoma; Cancer; Medical care;
D O I
10.1007/s42399-022-01208-y
中图分类号
学科分类号
摘要
Kaposi’s sarcoma (KS) is an important health problem that develops with the proliferation of vascular endothelial and perivascular connective tissue cells and that holds many foci in the body. While involvement of skin and mucosa is at the forefront of human immunodeficiency virus (HIV)-associated Kaposi’s sarcoma, its symptoms may be asymptomatic in purple colour as macule or nodule. In the presence of gastrointestinal system involvement, symptoms such as weight loss, abdominal pain, diarrhoea, vomiting, or bleeding can be seen. This study was conducted to determine the care needs of a case diagnosed with HIV-associated Kaposi’s sarcoma, to plan nursing interventions and to evaluate the results. The manuscript type is a case report. A 37-year-old male patient, in June 2018, purple nodular skin lesions that started on the arms and then spread throughout the body were observed. In addition to the lesions, the symptoms such as dry cough, night sweat, and nasal convection have also developed on the patient. As a result of lesion biopsy performed on 27.07.2018, the patient was diagnosed with Kaposi’s sarcoma. HIV RNA viral load quantify by PCR (RealStar®, Altona Diagnostics, Germany) result, which was examined on 10.08.18, of the patient with about 6 weight loss in this process was found as quantitative positive; 179.000 cpy/mL. Carboplatin and liposomal doxorubicin chemotherapy treatment was started on the patient who received Genova 1 × 200 mg for HIV treatment. As a result of computed tomography (CT), it was spotted that there were several nodules in the liver, abdomen, and lung. On April 1, 2019, the patient who received outpatient chemotherapy developed respiratory distress, and the patient applied to the hospital. The respiratory rate of the patient, who was taken to intensive care unit, was measured as 30/min, his saturation as 90%, and heart rate as 112/min and blood pressure as 70/30 mmHg. Subsequently, the patient was followed up with endotracheal intubation. As a result of collaborative interventions implemented in the line with care plan, it was determined that the symptoms regressed, the risks that could develop in the patient were prevented, and the life quality of the patient increased. When the literature was examined, there were not enough studies about medical care in HIV-associated Kaposi’s sarcoma disease. Therefore, it was considered that this shared case will guide the medical care of patients that are undergoing Kaposi’s sarcoma treatment.
引用
收藏
相关论文
共 50 条
  • [31] Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: A nested case-control study
    Wakeham, Katie
    Johnston, W. Thomas
    Nalwoga, Angela
    Webb, Emily L.
    Mayanja, Billy N.
    Miley, Wendell
    Elliott, Alison M.
    Whitby, Denise
    Newton, Robert
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (12) : 2822 - 2830
  • [32] Evaluation of treatments for HIV-associated Kaposi sarcoma in Africa
    Krown, Susan E.
    Borok, Margaret Z.
    [J]. INFECTIOUS AGENTS AND CANCER, 2021, 16 (01)
  • [33] Immunotherapy in HIV-associated Kaposi Sarcoma: Challenges and Prospects
    Tawana, Tiiso
    du Plessis, Julianne
    Omar, Aadilah
    [J]. CURRENT CANCER THERAPY REVIEWS, 2024,
  • [34] Evaluation of treatments for HIV-associated Kaposi sarcoma in Africa
    Susan E. Krown
    Margaret Z. Borok
    [J]. Infectious Agents and Cancer, 16
  • [35] HIV-associated cutaneous Kaposi's sarcoma - Palliative local treatment by radiotherapy
    Saran, FH
    Adamietz, IA
    Thilmann, C
    Mose, S
    Bottcher, HD
    [J]. ACTA ONCOLOGICA, 1997, 36 (01) : 55 - 58
  • [36] Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma
    Cainelli, Francesca
    Vallone, Alfredo
    [J]. BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 385 - 390
  • [37] The impact of histological grading in predicting outcome of HIV-associated Kaposi's sarcoma
    Cathomas, Gieri
    El Amari, Emmanuel Boffi
    Toutous-Trellu, Laurence
    Baumann, Michele
    Erb, Peter
    Steffen, Ingrid
    Muller, Nicolas
    Hirschel, Bernard
    [J]. VIRCHOWS ARCHIV, 2007, 451 (02) : 151 - 151
  • [38] Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report
    Julius, Peter
    Kang, Guobin
    Siyumbwa, Stepfanie
    Musumali, Jane
    Tso, For Yue
    Ngalamika, Owen
    Kaile, Trevor
    Maate, Fred
    Moonga, Phyllis
    West, John T.
    Angeletti, Peter
    Wood, Charles
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [39] HIV-Associated Kaposi Sarcoma in the Combination Antiretroviral Therapy Era
    Mangusan, Ralph E.
    Ekwede, Irene
    Widell, Anaida
    [J]. AMERICAN JOURNAL OF NURSING, 2022, 122 (12) : 32 - 40
  • [40] Oncologic Treatment of HIV-Associated Kaposi sarcoma 40 Years on
    Ramaswami, Ramya
    Lurain, Kathryn
    Yarchoan, Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (03) : 294 - +